Home / Tag Archives: BIO

Tag Archives: BIO

Aptuit SSCI Adds Ultra High Resolution Q-TOF Mass Spectrometer for Large & Small Molecule Analyses

GREENWICH, Connecticut, Aug. 22, 2014 /PRNewswire/ — Aptuit LLC announces that Aptuit SSCI, located in West Lafayette, Indiana, has enhanced its capabilities in the areas of structure determination and characterization of small and large molecules,…

Read More »

China Cord Blood Corporation to Report First Quarter of Fiscal 2015 Financial Results

Earnings Call Scheduled for 8:00 a.m. ET on August 29, 2014 HONG KONG, Aug. 21, 2014 /PRNewswire/ — China Cord Blood Corporation (NYSE: CO) (the "Company") today announced its plan to release financial results for the first…

Read More »

Qionglai Facility (QLF) Schedules September for GMP Examination

CHENGDU, China, August 18, 2014 /PRNewswire/ — Tianyin Pharmaceutical Co., Inc. (NYSE MKT: TPI), a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) today…

Read More »

WuXi Facility Passes FDA Inspection for Manufacture of API

SHANGHAI, August 18, 2014 /PRNewswire/ — WuXiPharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, announced today that a manufacturing facility…

Read More »

Yew Bio-Pharm Group Reports 2014 Second Quarter Financial Results

Announces Price Increase for TCM Raw Materials to Support Profitably Objectives Adds Two New TCM Raw Material Customers HARBIN, China, August 15, 2014 /PRNewswire/ — Yew Bio-Pharm Group, Inc. (“Yew Bio” or the “Company”) (OTCBB:…

Read More »

Sinovac Reports Unaudited Second Quarter Financial Results

— Conference call scheduled for Friday, August 15, 2014 at 8:00 AM ET — BEIJING, August 15, 2014 /PRNewswire/ — Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today…

Read More »

PW Medtech Group Limited Completes Acquisition of 100% Share Equity of Tianxinfu

Enters Biological Materials Segment and Creates New Profit Growth Drivers Brings synergy through Outstanding Acquisition and Integration Capability HONG KONG, Aug. 6, 2014 /PRNewswire/ — PW Medtech Group Limited ("PW Medtech" or the "Company" and,…

Read More »